Skip to main content
. 2007 Feb 7;45(4):1261–1265. doi: 10.1128/JCM.01839-06

TABLE 1.

C. neoformans strains tested in this study and results of immunoserotyping and molecular identification of the serotype

Strain no. Strain name Isolationa
Immunologic serotyping
Molecular identification
Origin Site Methodb Result REA patternc Fragment size(s) (bp)d
1 H99 United States CSF Commercial kit A A 394
2 IHEM 11752 Congo CSF Commercial kit A A 400
3 IHEM 11753 Congo CSF Commercial kit A A 394
4 IHEM 11756 Congo CSF Commercial kit A A 394
5 IHEM 11757 Congo CSF Commercial kit A A 394
6 IHEM 11876 Congo CSF Commercial kit A A 394
7 IHEM 11877 Congo CSF Commercial kit A A 394
8 IHEM 11880 Congo CSF Commercial kit A A 394
9 IHEM 11882 Congo CSF Commercial kit A A 394
10 Tou Mali CSF Homemade Ab A A 394
11 Fat Congo CSF Homemade Ab A A 400
12 coc 119 Cochin, India CSF Homemade Ab A A 394
13 333 Gabon CSF Homemade Ab A A 394
14 2598 P Ivory Coast CSF Homemade Ab A A 394
15 g 57497 Gabon CSF Homemade Ab A A 394
16 Oug 1 Uganda CSF Homemade Ab A A 394
17 PP38 Cambodia CSF Homemade Ab A A 394
18 RV66254 Rwanda CSF Homemade Ab A A 394
19 3/768 Congo CSF Homemade Ab A A 394
20 Lim France CSF Homemade Ab D A 394
21 C3 Cambodia CSF Homemade Ab A A 394
22 C6 Cambodia CSF Homemade Ab A A 394
23 C7 Cambodia CSF Homemade Ab A A 394
24 Oug 7 Uganda CSF Homemade Ab A A 394
25 PP29 Cambodia CSF Homemade Ab A A 394
26 RV68535 Rwanda CSF Homemade Ab A A 394
27 RV68528 Rwanda CSF Homemade Ab A A 394
28 Tnn Ci France CSF Homemade Ab A A 394
29 g 59546 Gabon CSF Homemade Ab A A 394
30 RV66254 Rwanda CSF Homemade Ab A A 394
31 C57 Cambodia CSF Homemade Ab A A 394
32 C68 Cambodia CSF Homemade Ab A A 394
33 Oug 3 Uganda CSF Homemade Ab AD A 394
34 Oug 9 Uganda CSF Homemade Ab A A 394
35 PP43 Cambodia CSF Homemade Ab A A 394
36 241 Gabon CSF Homemade Ab A A 394
37 Tnn Mb France Blood mAb IF A A 394
38 Tnn Da France Blood mAb IF A A 394
39 Tnn Mo France CSF mAb IF A A 394
40 Bel Belgium CSF Commercial kit A A 394
41 IHEM 4157 Belgium NS Commercial kit AD AD 382, 394
42 IHEM 13877 Belgium CSF Commercial kit AD AD 382, 394
43 IHEM 14440 Belgium CSF Commercial kit AD AD 382, 394
44 IHEM 16079 Belgium Voice prosthesis Commercial kit AD AD 382, 394
45 IHEM 16513 Peru CSF Commercial kit AD AD 382, 394
46 IHEM 17861 Peru CSF Commercial kit AD AD 382, 394
47 RV 66423 Rwanda CSF Homemade Ab A D 382
48 JEC21 NS NS Commercial kit D D 382
49 B 3501 A NS NS Commercial kit D D 382
50 NIH D52 United States CSF Commercial kit D D 382
51 IHEM 15038 Peru NS Commercial kit D D 382
52 IHEM 18620 Belgium Skin Commercial kit D D 382
53 IHEM 16711 Belgium Skin Commercial kit D D 382
54 IHEM 4158 Italy NS Commercial kit D D 382
55 AKD 30 Ivory Coast CSF Homemade Ab A D 380
56 T 6073 France CSF Homemade Ab D D 382
57 2815 Cambodia CSF Homemade Ab A D 382
58 Tnn Re France BAL fluid mAb IF D D 382
59 JLP34 France CSF mAb IF D D 382
60 JLP23 France Urine mAb IF D D 382
61 IHEM 11758 Congo CSF Commercial kit D D 380
62 C9 Cambodia CSF Homemade Ab A D 382
63 IHEM 14934 Brazil NS Commercial kit B B 373
64 IHEM 4161e United States Sputum Commercial kit B B 373
65 IHEM 11796e Zaire CSF Commercial kit B B 373
66 IHEM 4170 Malaysia NS Commercial kit B B 373
67 IHEM 4164 China CSF Commercial kit B B 371
68 WM 276 Australia Environment Commercial kit B B 371
69 VanR265 Canada BWF Commercial kit B B 380
70 RV68522 Rwanda CSF Homemade Ab D B 371
71 IHEM 10079 NS CSF Commercial kit C C 366
72 IHEM 4159e United States CSF Commercial kit C C 366
a

NS, not specified; CSF, cerebrospinal fluid; BAL, bronchoalveolar lavage; BWF, bronchial wash fluid; Congo, Democratic Republic of the Congo.

b

The commercial kit used was the Crypto Check kit (Iatron Labs, Tokyo, Japan). Homemade Ab, agglutination with homemade antisera (9); mAb IF, immunofluorescence with monoclonal antibody specific for CPS (3).

c

REA pattern deduced from in silico analysis (Table 2).

d

PCR fragments are supposed to be 8 bases longer than the sequences due to a 7-base tail added to the reverse primer used to promote the addition of an extra A to the amplified fragment.

e

Type strain.